GRP Seized 10.87 Lakh Ml Of Oxytocin Worth Rs 1.94 Cr At Charbagh Railway Station

Lucknow:  GRP has seized banned drug Oxytocin worth Rs 1.94 crore at Charbagh railway station in the capital Lucknow. It was recovered from the parcel office of Lucknow Junction station. The drug was brought from Bihar by Chhapra-Lucknow Junction Express. A case has been registered and investigation is underway.

Charbagh GRP in-charge Mukesh Singh said that this action has been taken under ‘Operation Satark’. On November 14, information was received from an informer that banned oxytocin drug is being brought illegally to Lucknow by 15053 Chhapra-Lucknow Junction Express. This drug is in a shipment of 43 Cartoons. Five Cartoons have been taken by the party and the rest are reaching Lucknow.

Showing alertness on this, the team of Sub-Inspector Prashant Singh Yadav inspected the parcel office at 2 pm. 38 Cartoons were recovered, which had no receiver. Complete details of the parcel packets were obtained from Sanjeev Chaudhary, Commercial Superintendent of Northeast Railway Lucknow Division, in which details of sending the packets and to whom they were sent were found.

The team kept waiting for the receiver of the packages. But, no one came to receive them. After this, GRP seized the banned drug. It was further told that a total of 10.87 lakh ml of suspected oxytocin has been recovered. Its cost is said to be Rs 1,93,73,904. Santosh Singh, a resident of Chhapra, Bihar was named as the sender of the parcel and it was sent to Ram Lautan, a resident of Sitapur.

In such a situation, considering the names printed on the packets and the possibility of many more people being involved in this smuggling, GRP has registered a case under the Railway Act. Along with two named accused, a case has been filed against others under the Railway Act.

Related Posts

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

The report emphasizes that absolute R&D spending remains modest and identifies expanding investment in advanced biologics and AI-driven drug discovery as the “largest opportunity” for bridging the innovation divide. Recent…

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Early-stage activity drove the month, accounting for 73.6 per cent of total investments, while seed-stage rounds contributed the remaining 26.4 per cent. India’s pharma and healthcare funding for November 2025…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India’s Pharma Sector Must Expand AI Use Beyond R&D: Reports

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India headed for Culture of ‘Divya Buildings’, thanks to AMTZ’s Landmark Initiative

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

India’s Pharma, Healthcare Funding Hits $38.6 Mn in Nov’25

Novo Nordisk gears up for December Ozempic launch

Novo Nordisk gears up for December Ozempic launch

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Illegal intoxicant tablets seized in large quantity from Sirsa medical store, two held

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit

Higher pharma, chemicals exports to Russia bloc on agenda to trim deficit